Timothy J Yen Selected Research

Nervous System Diseases (Neurological Disorders)

1/2015

Changing the selectivity of p300 by acetyl-CoA modulation of histone acetylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy J Yen Research Topics

Disease

12	Neoplasms (Cancer) 10/2019 - 01/2007
4	Melanoma (Melanoma, Malignant) 06/2022 - 01/2017
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2019 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 10/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 01/2014
1	Genomic Instability 10/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2015
1	Werner Syndrome (Werner's Syndrome) 12/2015
1	Heart Diseases (Heart Disease) 01/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Cardiotoxicity 01/2015
1	Adenocarcinoma 02/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014
1	Chromosomal Instability (Chromosome Stability) 12/2013
1	Leukemia 09/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2007
6	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2019 - 01/2007
4	Gemcitabine FDA Link 03/2018 - 01/2014
4	Phosphotransferases (Kinase)IBA 01/2018 - 10/2007
2	Thymine DNA GlycosylaseIBA 06/2022 - 01/2019
2	VemurafenibIBA 03/2018 - 01/2017
2	dabrafenibIBA 03/2018 - 01/2017
2	Serine (L-Serine)FDA Link 03/2018 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 02/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 02/2014 - 01/2014
1	ThymineIBA 10/2019
1	UracilIBA 10/2019
1	A-Form DNA (A-DNA)IBA 10/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	5-carboxylcytosineIBA 01/2019
1	NucleosidesIBA 03/2018
1	encorafenibIBA 03/2018
1	Methotrexate (Mexate)FDA LinkGeneric 03/2018
1	adavosertibIBA 01/2018
1	EnzymesIBA 01/2017
1	RecQ HelicasesIBA 12/2015
1	Histones (Histone)IBA 01/2015
1	pixantrone (BBR 2778)IBA 01/2015
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2015
1	AnthraquinonesIBA 01/2015
1	Carboplatin (JM8)FDA LinkGeneric 02/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2014
1	Messenger RNA (mRNA)IBA 02/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 02/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2014
1	bosutinibIBA 01/2014
1	ChromatinIBA 12/2013
1	Rho Guanine Nucleotide Exchange FactorsIBA 09/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2007
1	AphidicolinIBA 10/2007

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2007
1	Drug Therapy (Chemotherapy) 02/2014